Company Description

Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products.

The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure.

The company operates in the United States, Europe, and internationally. The company was incorporated in 2021 and is headquartered in Tucson, Arizona.

Picard Medical, Inc. operates as a subsidiary of Hunniwell Picard I, Llc.

Picard Medical, Inc.

Country	United States
Founded	1981
IPO Date	Aug 29, 2025
Industry	Medical Devices
Sector	Healthcare
Employees	75
CEO	Patrick Schnegelsberg

Contact Details

Address: 1992 East Silverlake Road Tucson, Arizona 85713 United States
Phone	520 545 1234
Website	picardmedical.com

Stock Details

Ticker Symbol	PMI
Exchange	NYSEAMERICAN
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
IPO Price	$4.00
CIK Code	2030617
CUSIP Number	71953R108
ISIN Number	US71953R1086
SIC Code	3841

Key Executives

Name	Position
Patrick N. J. Schnegelsberg	Chief Executive Officer and Director
Bernard Skaggs	Chief Financial Officer
Matthew Schuster	Chief Operating Officer
Dr. Frank Tinker Ph.D.	Chief Technology Officer of SynCardia Systems, LLC

Latest SEC Filings

Date	Type	Title
May 15, 2026	10-Q	Quarterly Report
May 15, 2026	10-K/A	[Amend] Annual report
May 11, 2026	8-K	Current Report
May 6, 2026	424B4	Prospectus
May 5, 2026	8-K	Current Report
May 4, 2026	EFFECT	Notice of Effectiveness
May 1, 2026	S-1/A	[Amend] General form for registration of securities under the Securities Act of 1933
Apr 27, 2026	S-1	General form for registration of securities under the Securities Act of 1933
Apr 22, 2026	8-K	Current Report
Apr 14, 2026	DRS	[Cover] Draft Registration Statement

View All SEC Filings